Developing a thrombopoietin inhibitor to treat NF2 hearing loss and schwannoma growth

syn61831970

Created By NF Service nf-osi-service

grantDOI: https://doi.org/10.48105/CTF.CTF-2023-05-003.pc.gr.172001
studyName: Developing a thrombopoietin inhibitor to treat NF2 hearing loss and schwannoma growth
dataStatus: Under Embargo
initiative: Drug Discovery Initiative
studyLeads: Lawrence Sherman
studyStatus: Active
diseaseFocus: Neurofibromatosis type 2
grantEndDate: 1751328000000
institutions: Oregon Health and Science University
fundingAgency: CTF
manifestation: Schwannoma
embargoEndDate: 1782864000000
grantStartDate: 1688169600000
studyFileviewId: syn61831977
syn61831971
syn61832057
syn61831972
syn61831977
syn61831973

Your web browser must have JavaScript enabled in order for this application to display correctly.
If you are an automated web crawler from a search engine, follow this AJAX application crawl link

Developing a thrombopoietin inhibitor to treat NF2 hearing loss and schwannoma growth

syn61831970

Drop files to upload

Developing a thrombopoietin inhibitor to treat NF2 hearing loss and schwannoma growth page is loading…